No Data
No Data
IVD Medical Holding (HKG:1931) Seems To Use Debt Rather Sparingly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to rui
IVD Medical Holding Enters MOU With Prospective Chinese Partner; Shares Rise 3%
IVD Medical Holding (HKG:1931) entered into a non-legally binding memorandum of understanding (MOU) with an undisclosed prospective partner in China, a Wednesday filing said. Under the agreement, both
IVD Medical: In Exclusivity Period With Prospective Partner for 12 Months
IVD Medical: In Exclusivity Period With Prospective Partner for 12 Months
IVD Medical: Cooperation Could Include Capital Injection by Prospective Partner
IVD Medical: Cooperation Could Include Capital Injection by Prospective Partner
IVD Medical: Signed Agreement With Prospective Partner for Business Cooperation
IVD Medical: Signed Agreement With Prospective Partner for Business Cooperation
Huajian Medical (01931.HK) signed a memorandum of understanding on investment cooperation with an in vitro diagnostic company
Gelonghui, May 29丨Huajian Healthcare (01931.HK) announced that on May 29, 2024, the company signed a non-legally binding memorandum of understanding with a potential partner (“potential partner”) in China on investment cooperation matters. Established in 2011, the potential partner is an in vitro diagnostic enterprise centered on chemiluminescence technology and products. Potential partners have established a chemiluminescence technology platform based on alkaline phosphatase. The chemiluminescence reagent testing function list includes sex hormones, tumor markers, thyroid function hormones, renal function tests, bone metabolism, myocardial markers,
No Data